A groundbreaking new review article, titled “Recent advances in precise synthesis, functional modification and multidisease theranostic applications of layered double hydroxide nanomaterials,” offers a definitive roadmap for the next generation of smart nanomedicine. Published in Frontiers of Materials Science, this comprehensive study synthesizes decades of research to highlight the transformative potential of layered double hydroxides (LDHs) in treating complex diseases ranging from cancer to neurodegenerative disorders.

LDHs, often referred to as “anionic clays,” have emerged as a superstar in the field of nanobiomaterials. Their unique layered structure allows for the precise loading of drugs, genes, and imaging agents, making them ideal candidates for theranostics—a cutting-edge approach that combines therapy and diagnosis in a single platform.

This extensive review systematically analyzes the evolution of LDHs, moving from fundamental synthesis to advanced clinical applications. The authors provide critical insights into:

• Precision Synthesis & Modification: A deep dive into advanced preparation methods—including microfluidics and hydrothermal synthesis—that allow for strict control over particle size and morphology, essential for clinical translation.
• Multimodal Imaging: How LDHs are being engineered to serve as contrast agents for MRI, CT, and fluorescence imaging, enabling real-time visualization of disease sites.
• Targeted Disease Treatment: Detailed analysis of LDH applications in oncology (targeted drug delivery and immunotherapy), orthopedics (bone regeneration), and neurology (crossing the blood‒brain barrier for Alzheimer’s and Parkinson’s treatment).
• Smart Responsiveness: The development of “intelligent” LDHs that respond to specific stimuli—such as pH changes or light—to release drugs exactly where needed, minimizing systemic toxicity.

The review underscores that while LDHs have shown immense promise, the path to clinical application requires overcoming challenges related to long-term biosafety and large-scale manufacturing. “We aim to provide a comprehensive reference that bridges the gap between material science and clinical needs,” said the lead author. “By integrating artificial intelligence with high-throughput synthesis, we believe LDHs will play a pivotal role in the future of personalized precision medicine.”

This article serves as an essential resource for researchers, pharmacologists, and medical professionals seeking to understand the trajectory of inorganic nanomaterials in healthcare.
DOI：10.1007/s11706-026-0781-0